Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Tengion Announces Continued Clinical Progress on Key Milestones for Neo-Urinary Conduit™ 

 

 

Tengion Announces Continued Clinical Progress on Key Milestones for Neo-Urinary Conduit™

June 11, 2012 - (Tengion) - “Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced continued clinical progress on key milestones for the ongoing Phase 1 trial of the Company's most advanced product candidate, the Neo-Urinary Conduit.”  Read Full Article

 

Posted on 2-Jul-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: